This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Park, Steven
| Item Type | Name |
|
Concept
|
Humans
|
|
Concept
|
Lymphoma, T-Cell
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Cell Cycle
|
|
Concept
|
Lymphoma, Mantle-Cell
|
|
Concept
|
Animals
|
|
Concept
|
Aged
|
|
Concept
|
Lymphoma, T-Cell, Cutaneous
|
|
Concept
|
Adolescent
|
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
|
Concept
|
Mice
|
|
Concept
|
Outpatients
|
|
Concept
|
Adult
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Middle Aged
|
|
Concept
|
Young Adult
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Cell Line, Tumor
|
|
Academic Article
|
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
|
|
Academic Article
|
A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus.
|
|
Academic Article
|
Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
|
|
Academic Article
|
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.
|
|
Academic Article
|
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
|
|
Academic Article
|
Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma.
|
|
Academic Article
|
Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.
|
|
Academic Article
|
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy.
|
|
Academic Article
|
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.
|
|
Academic Article
|
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma.
|
|
Academic Article
|
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
|
|
Academic Article
|
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.
|
|
Academic Article
|
Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.
|
|
Academic Article
|
High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles.
|
|
Academic Article
|
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma.
|
- Lymphoma
- Large
- B
- Cell
- Diffuse